๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT ยท Real-Time Price ยท USD
1.500
-0.020 (-1.32%)
At close: Nov 18, 2026, 4:00 PM EST
1.480
-0.020 (-1.33%)
After-hours: Nov 18, 2026, 6:02 PM EST

ZYBT Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
104.98116.36186.36211.65260.27214.07
Revenue Growth
-9.78%-37.56%-11.95%-18.68%21.58%-
Gross Profit
21.2323.8791.3117.51147.88124.62
Operating Income
-62.45-70.5116.4444.9965.8352.47
Net Income
-67.03-69.7811.3131.4646.7438.96
Earnings Per Share
-1.41-1.470.250.691.020.85
EPS Growth
---64.04%-32.69%19.96%-

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
33.1751.8920.0416.39.756.28
Total Debt
78.975.0886.5889.8564.8830
Net Cash (Debt)
-45.73-23.19-66.54-73.55-55.13-23.72
Net Cash Growth
------
Net Cash Per Share
-0.96-0.49-1.46-1.61-1.21-0.52

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
10.4913.3341.0548.1817.3431.81
Capital Expenditures
-4.13-1.01-13.59-7.4-27.33-19.06
Free Cash Flow
6.3612.3327.4640.79-9.9912.75
Free Cash Flow Growth
-48.41%-55.12%-32.68%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
20.23%20.51%48.99%55.52%56.82%58.22%
Operating Margin
-59.49%-60.59%8.82%21.25%25.30%24.51%
Pretax Margin
-60.24%-61.77%7.72%20.68%24.56%24.79%
Profit Margin
-63.85%-59.97%6.07%14.86%17.96%18.20%
FCF Margin
6.06%10.59%14.74%19.27%-3.84%5.96%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
74.5530.93----
PS Ratio
4.603.28----